Wang X, Shang Y, Zhang J, Liu J, et al. Survival outcomes of neoadjuvant versus adjuvant therapy in patients with T1c, node-negative, human epidermal growth factor receptor 2-positive breast cancer: A Surveillance, Epidemiology, and End Results population-based study. Cancer 2024 Sep 22. doi: 10.1002/cncr.35581.
PMID: 39306696